Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Essen Biotech
- Target Recruit Count
- 75
- Registration Number
- NCT06213636
- Locations
- 🇨🇳
District One Hospital, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath